Fundación Pública Andaluza Progreso y Salud
Welcome,         Profile    Billing    Logout  
 9 Trials 
16 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Román, Antonio Rivero
NCT06694805: A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Recruiting
3
332
Europe, US
CAB LA + RPV LA, Oral ART
ViiV Healthcare
HIV Infections
05/26
12/27
NCT04772833: Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19

Recruiting
N/A
50
Europe
Autopsy
Maimónides Biomedical Research Institute of Córdoba, Spanish Society of Infectious Diseases and Clinical Microbiology, Spanish Society of Pathological Anatomy
Covid19
12/21
12/21
Pérez, Francisco Téllez
NCT04090580: Impact on Glycemic Variability After Treatment With Dapagliflozin on Type 2 Diabetes Patients

Recruiting
4
88
RoW
Continuous glucose monitoring
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, AztraZeneca
Type 2 Diabetes
12/21
12/21
REMOVE, NCT05151861: Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy:

Recruiting
4
60
Europe
Complete removal of pharmacological treatment, Control
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Heart Failure
11/22
05/23
NCT04127994: Glycemic Variability Comparing Two vs Six Meals in Type 2 Diabetes

Recruiting
N/A
50
RoW
Comparing 3 versus 6 meals in type 2 diabetes patients
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, L.N. Adrián Romero Villaseñor, L.N. Aurora Ramos Flores, L.N. Mariana Galindo Guzmán, Dr. Daniel Cuevas Ramos, Dr. Adrian Soto Mota, Dr. Francisco J. Gómez Pérez, Dr. Alfonso Gulias Herrero, Lucía Palacios Baez, Gerardo Saavedra Jiménez, Hector Donaldo Espinosa Salazar, Issa Lill Santiago Falfán, Cristina Aurora Tlapanco Beltrán, Horacio Correa Carranza, Alejandra Dominguez Sanchez
Diabetes Mellitus Type 2, Overweight and Obesity, Meal Time
10/23
10/23
NCT06418932: Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure

Recruiting
N/A
106
Europe
UrgoK2 / UrgoK2 Lite, Controll
Fundación para la Investigación del Hospital Clínico de Valencia
Heart Failure
07/26
07/26
Camacho, Inés Pérez
STI_PrEPare, NCT06860945: Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in Spain

Recruiting
N/A
9000
Europe
No Intervention: Observational Cohort
Hospital Universitario de Valme, Instituto de Salud Carlos III
Sexually Transmitted Infections (STIs), HIV, PrEP
06/25
01/26
Morales, Josefa Ruiz
AFFINITY, NCT04573920: Atrasentan in Patients With Proteinuric Glomerular Diseases

Active, not recruiting
2
103
Europe, US, RoW
Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627
Novartis Pharmaceuticals
IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Immunoglobulin A Nephropathy
07/24
07/26
Méndez, Francisco Vera
LOVER60, NCT06646562: Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

Recruiting
4
120
Europe
Cabotegravir LA + Rilpivirine LA
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia, ViiV Healthcare
HIV-1 Infected Adults with Controlled Viremia
01/26
01/27
Aguilera, Nuria Espinosa
NCT05140603: Ambispective Cohort Study to Evaluate the Efficacy, Safety, and Tolerance of an Antiretroviral Regimen With Doravirine

Not yet recruiting
N/A
150
Europe
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Hiv
07/23
10/23
Ortega, Federico Pulido
VOGUE, NCT05979311: A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy

Recruiting
3
412
Europe, Japan, RoW
Dolutegravir, Lamivudine, Bictegravir, Emtricitabine, Tenofovir alafenamide
ViiV Healthcare
HIV, HIV Infections
11/25
10/26
García, Juan González
NCT05590403 / 2022-001981-36: A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above

Completed
3
1544
NA
RSVPreF3 OA investigational vaccine, Placebo
GlaxoSmithKline
Respiratory Syncytial Virus Infections
03/23
02/24
NCT05788497: Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids

Terminated
3
21
Europe
Hemorrane plus, Hemorrane, Placebo
Faes Farma, S.A., Dynamic Science S.L.
Haemorrhoids Without Complication
01/24
01/24
NCT05293236: ApTOLL for the Treatment of COVID-19

Terminated
1
5
Europe
ApTOLL, Saline
Macarena Hernández Jiménez, Centro para el Desarrollo Tecnológico Industrial
COVID-19
12/22
12/22
NCT05597774: Effects of Respiratory Muscle Training in Individuals With Long-term Post-COVID-19 Symptoms

Completed
N/A
64
Europe
Inspiratory + expiratory muscle training group, Inspiratory + expiratory muscle training sham group, Exercise training program
Universidad Complutense de Madrid, Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
Covid19, Post-acute COVID-19 Syndrome
09/23
09/23
EVAR-markers, NCT06866769: Efficacy of Biomarkers and CEUS Versus CTA in AAA Follow-up Post-EVAR

Recruiting
N/A
60
Europe
CTA, Ultrasound image enhancement
Instituto de Investigacion Sanitaria La Fe
Abdominal Aortic Aneurysm Without Rupture
07/25
04/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Román, Antonio Rivero
NCT06694805: A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Recruiting
3
332
Europe, US
CAB LA + RPV LA, Oral ART
ViiV Healthcare
HIV Infections
05/26
12/27
NCT04772833: Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19

Recruiting
N/A
50
Europe
Autopsy
Maimónides Biomedical Research Institute of Córdoba, Spanish Society of Infectious Diseases and Clinical Microbiology, Spanish Society of Pathological Anatomy
Covid19
12/21
12/21
Pérez, Francisco Téllez
NCT04090580: Impact on Glycemic Variability After Treatment With Dapagliflozin on Type 2 Diabetes Patients

Recruiting
4
88
RoW
Continuous glucose monitoring
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, AztraZeneca
Type 2 Diabetes
12/21
12/21
REMOVE, NCT05151861: Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy:

Recruiting
4
60
Europe
Complete removal of pharmacological treatment, Control
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Heart Failure
11/22
05/23
NCT04127994: Glycemic Variability Comparing Two vs Six Meals in Type 2 Diabetes

Recruiting
N/A
50
RoW
Comparing 3 versus 6 meals in type 2 diabetes patients
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, L.N. Adrián Romero Villaseñor, L.N. Aurora Ramos Flores, L.N. Mariana Galindo Guzmán, Dr. Daniel Cuevas Ramos, Dr. Adrian Soto Mota, Dr. Francisco J. Gómez Pérez, Dr. Alfonso Gulias Herrero, Lucía Palacios Baez, Gerardo Saavedra Jiménez, Hector Donaldo Espinosa Salazar, Issa Lill Santiago Falfán, Cristina Aurora Tlapanco Beltrán, Horacio Correa Carranza, Alejandra Dominguez Sanchez
Diabetes Mellitus Type 2, Overweight and Obesity, Meal Time
10/23
10/23
NCT06418932: Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure

Recruiting
N/A
106
Europe
UrgoK2 / UrgoK2 Lite, Controll
Fundación para la Investigación del Hospital Clínico de Valencia
Heart Failure
07/26
07/26
Camacho, Inés Pérez
STI_PrEPare, NCT06860945: Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in Spain

Recruiting
N/A
9000
Europe
No Intervention: Observational Cohort
Hospital Universitario de Valme, Instituto de Salud Carlos III
Sexually Transmitted Infections (STIs), HIV, PrEP
06/25
01/26
Morales, Josefa Ruiz
AFFINITY, NCT04573920: Atrasentan in Patients With Proteinuric Glomerular Diseases

Active, not recruiting
2
103
Europe, US, RoW
Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627
Novartis Pharmaceuticals
IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Immunoglobulin A Nephropathy
07/24
07/26
Méndez, Francisco Vera
LOVER60, NCT06646562: Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

Recruiting
4
120
Europe
Cabotegravir LA + Rilpivirine LA
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia, ViiV Healthcare
HIV-1 Infected Adults with Controlled Viremia
01/26
01/27
Aguilera, Nuria Espinosa
NCT05140603: Ambispective Cohort Study to Evaluate the Efficacy, Safety, and Tolerance of an Antiretroviral Regimen With Doravirine

Not yet recruiting
N/A
150
Europe
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Hiv
07/23
10/23
Ortega, Federico Pulido
VOGUE, NCT05979311: A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy

Recruiting
3
412
Europe, Japan, RoW
Dolutegravir, Lamivudine, Bictegravir, Emtricitabine, Tenofovir alafenamide
ViiV Healthcare
HIV, HIV Infections
11/25
10/26
García, Juan González
NCT05590403 / 2022-001981-36: A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above

Completed
3
1544
NA
RSVPreF3 OA investigational vaccine, Placebo
GlaxoSmithKline
Respiratory Syncytial Virus Infections
03/23
02/24
NCT05788497: Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids

Terminated
3
21
Europe
Hemorrane plus, Hemorrane, Placebo
Faes Farma, S.A., Dynamic Science S.L.
Haemorrhoids Without Complication
01/24
01/24
NCT05293236: ApTOLL for the Treatment of COVID-19

Terminated
1
5
Europe
ApTOLL, Saline
Macarena Hernández Jiménez, Centro para el Desarrollo Tecnológico Industrial
COVID-19
12/22
12/22
NCT05597774: Effects of Respiratory Muscle Training in Individuals With Long-term Post-COVID-19 Symptoms

Completed
N/A
64
Europe
Inspiratory + expiratory muscle training group, Inspiratory + expiratory muscle training sham group, Exercise training program
Universidad Complutense de Madrid, Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
Covid19, Post-acute COVID-19 Syndrome
09/23
09/23
EVAR-markers, NCT06866769: Efficacy of Biomarkers and CEUS Versus CTA in AAA Follow-up Post-EVAR

Recruiting
N/A
60
Europe
CTA, Ultrasound image enhancement
Instituto de Investigacion Sanitaria La Fe
Abdominal Aortic Aneurysm Without Rupture
07/25
04/28

Download Options